Azathioprine-induced destructive cholangitis [16]

American Journal of Gastroenterology

Volumn 96, Issue 2, 2001, Pages 616-617

  Sobesky, Rodolphe ^a,b   Dusoleil, Alain ^a   Condat, Bertrand ^a   Bedossa, Pierre ^a   Buffet, Catherine ^a   Pelletier, Gilles ^a  

^a BICÊTRE HOSPITAL   (France)

^b Service des Maladies du Foie et de l'Appareil Digestif   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; ALLOPURINOL; AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; LIVER ENZYME; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; BILE DUCT DISEASE; BILIARY CIRRHOSIS; CASE REPORT; CHOLANGITIS; CHOLESTASIS; CLINICAL FEATURE; DRUG EFFECT; DRUG RESPONSE; HUMAN; JAUNDICE; LETTER; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; PRIORITY JOURNAL; SYMPATHETIC OPHTHALMIA; SYMPTOM; TREATMENT OUTCOME;

EID: 0035127276     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02375-3     Document Type: Letter

References (6)

1. Antineoplastic agents and the liver
2. Reversible cholestasis with bile duct injury following azathioprine therapy. A case report
3. Cholestasis after azathioprine administration in renal transplant recipient; report of 7 cases
4. Azathioprine and the liver. Evidence favoring idiosyncrasic, mixed cholestatic-hepatocellular injury in humans
5. Drug-induced cholestasis
6. Vanishing bile duct syndrome in drug-induced liver disease